Program Information
Source Modeling and VMAT Quality Assurance Referring to the TrueBeam Representative Beam Data for Eclipse
Q Wu*, Beijing Hospital, Beijing, China
Presentations
SU-F-T-276 (Sunday, July 31, 2016) 3:00 PM - 6:00 PM Room: Exhibit Hall
Purpose: To study quality assurance (QA) of volumetric modulated arc therapy (VMAT) after the 6MV and 10MV photon beam source modeling, referring to the Varian TrueBeam representative beam data for Eclipse.
Methods: The source model needs specific measured beam data, such as PDDs and profiles, diagonal profile, output factors (OFs), and MLC transmission factor (TF) and dosimetric leaf gap (DLG), et al. We downloaded the representative data from myVarian website, which includes TrueBeam 4MV-15MV photon beam data and 6MeV-22MeV electron beam data in w2CAD file format for use with Eclipse and in Excel spreadsheet format for use in data comparison. The beam data in W2CAD format can be imported into the Eclipse system and calibrated for use, as appropriate. We used PTW MP3 water tank to measure the beam data in some typical field sizes, and compared the measured data with the representative data. We found that the PDDs, profiles and OFs are similar. However according to some papers and our measurements, we decided that our MLC TF and DLG are 1.58 and 1.33 (6MV), 1.79 and 1.57 (10MV), respectively. After we had configured the anisotropic analytical algorithm (AAA) with the representative data in Eclipse, we also have done dosimetric verification for 88 VMAT plans.
Results: The end-to-end test procedures of VMAT were performed for 6MV and 10MV energy modes. The NE Farmer ion chamber mean measurements showed 1.2% (6MV, 38 cases) and 1.2% (10MV, 50 cases) between measurement and calculation; the Sun Nuclear ArcCheck mean measurements demonstrated gamma pass rates are as followings: 98.9%, 93.2%, 61.0% for 6MV, and 98.9%, 91.9%, 59.5% for 10MV, using 3%/3mm, 2%/2mm, 1%/1mm, 10% threshold criteria, respectively.
Conclusion: The representative data is applicable to our TrueBeam for the VMAT plan, though our MLC factors are a little different, and its patient-specific QA is good.
Contact Email: